A detailed history of Lindbrook Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Lindbrook Capital, LLC holds 61,431 shares of PFE stock, worth $1.58 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
61,431
Previous 69,978 12.21%
Holding current value
$1.58 Million
Previous $1.96 Million 9.2%
% of portfolio
0.15%
Previous 0.19%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$27.7 - $31.39 $236,751 - $268,290
-8,547 Reduced 12.21%
61,431 $1.78 Million
Q2 2024

Jul 31, 2024

BUY
$25.26 - $29.6 $182,831 - $214,244
7,238 Added 11.54%
69,978 $1.96 Million
Q1 2024

Apr 25, 2024

BUY
$25.89 - $29.73 $38,886 - $44,654
1,502 Added 2.45%
62,740 $1.74 Million
Q4 2023

Jan 31, 2024

SELL
$26.13 - $33.94 $372,666 - $484,052
-14,262 Reduced 18.89%
61,238 $1.76 Million
Q3 2023

Oct 25, 2023

SELL
$32.09 - $37.51 $146,619 - $171,383
-4,569 Reduced 5.71%
75,500 $2.5 Million
Q2 2023

Jul 28, 2023

BUY
$36.12 - $41.79 $69,169 - $80,027
1,915 Added 2.45%
80,069 $2.94 Million
Q1 2023

Apr 26, 2023

SELL
$39.39 - $51.28 $72,083 - $93,842
-1,830 Reduced 2.29%
78,154 $3.19 Million
Q4 2022

Jan 24, 2023

BUY
$41.75 - $54.5 $220,648 - $288,032
5,285 Added 7.08%
79,984 $0
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $86,032 - $105,023
1,966 Added 2.7%
74,699 $3.27 Million
Q2 2022

Aug 01, 2022

BUY
$46.53 - $55.17 $211,897 - $251,244
4,554 Added 6.68%
72,733 $3.81 Million
Q1 2022

Apr 21, 2022

BUY
$45.75 - $56.69 $114,558 - $141,951
2,504 Added 3.81%
68,179 $3.53 Million
Q4 2021

Jan 18, 2022

BUY
$41.32 - $61.25 $2.4 Million - $3.56 Million
58,083 Added 765.06%
65,675 $3.88 Million
Q3 2021

Nov 05, 2021

SELL
$39.25 - $50.42 $43,881 - $56,369
-1,118 Reduced 12.84%
7,592 $327,000
Q2 2021

Jul 27, 2021

SELL
$35.91 - $40.68 $1,005 - $1,139
-28 Reduced 0.32%
8,710 $341,000
Q1 2021

Apr 28, 2021

SELL
$33.49 - $37.77 $81,548 - $91,969
-2,435 Reduced 21.79%
8,738 $317,000
Q4 2020

Jan 27, 2021

BUY
$33.47 - $42.56 $24,633 - $31,324
736 Added 7.05%
11,173 $411,000
Q3 2020

Nov 03, 2020

SELL
$31.75 - $37.25 $105,187 - $123,409
-3,313 Reduced 24.09%
10,437 $383,000
Q2 2020

Jul 27, 2020

BUY
$30.12 - $36.54 $65,089 - $78,962
2,161 Added 18.65%
13,750 $450,000
Q1 2020

Apr 22, 2020

SELL
$27.03 - $38.62 $84,793 - $121,150
-3,137 Reduced 21.3%
11,589 $378,000
Q4 2019

Jan 27, 2020

BUY
$32.92 - $37.36 $27,455 - $31,158
834 Added 6.0%
14,726 $577,000
Q3 2019

Oct 31, 2019

SELL
$32.49 - $42.13 $45,453 - $58,939
-1,399 Reduced 9.15%
13,892 $499,000
Q2 2019

Jul 24, 2019

SELL
$36.98 - $41.52 $59,537 - $66,847
-1,610 Reduced 9.53%
15,291 $662,000
Q1 2019

Apr 23, 2019

SELL
$37.5 - $41.2 $45,562 - $50,058
-1,215 Reduced 6.71%
16,901 $717,000
Q4 2018

Feb 07, 2019

BUY
$38.47 - $43.86 $696,922 - $794,567
18,116 New
18,116 $790,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.